{"id":"NCT02278718","sponsor":"MediWound Ltd","briefTitle":"A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care","officialTitle":"A Multicenter, Multinational, Randomized, Controlled, Open Label Study, Performed in Children With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid as Compared to Standard of Care (SOC) Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-05","primaryCompletion":"2021-04","completion":"2022-12","firstPosted":"2014-10-30","resultsPosted":"2024-09-27","lastUpdate":"2024-09-27"},"enrollment":145,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Thermal Burns"],"interventions":[{"type":"DRUG","name":"NexoBrid","otherNames":[]},{"type":"PROCEDURE","name":"Standard of Care","otherNames":[]}],"arms":[{"label":"NexoBrid Gel","type":"EXPERIMENTAL"},{"label":"Standard of Care","type":"ACTIVE_COMPARATOR"}],"summary":"This study will be a two-arms study intending to demonstrate superiority of NexoBrid treatment over SOC in children with thermal burns. The study objective is to evaluate the safety and clinical benefit of NexoBrid in hospitalized children (0-17 years) with deep partial and/or full thickness thermal burns of 1-30% TBSA and to compare NexoBrid to standard of care (SOC).","primaryOutcome":{"measure":"Time to Complete Eschar Removal (in Days)","timeFrame":"From randomization date until complete eschar removal. For NexoBrid, assessed post application (post 2 h soaking) and for SOC assessed immediately post last dressing change for non-surgical SOC arm and immediately post excision for surgical SOC arm.","effectByArm":[{"arm":"NexoBrid Gel","deltaMin":0.99,"sd":null},{"arm":"Standard of Care","deltaMin":5.99,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0008"}]},"eligibility":{"minAge":"0 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":36,"countries":["United States","Belgium","Georgia","Germany","Hungary","India","Italy","Netherlands","Poland","Romania","Slovakia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["24074719"],"seeAlso":["http://www.ncbi.nlm.nih.gov/pubmed/?term=nexobrid"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":69},"commonTop":["Pruritus","Pain","Vomiting","Nausea","Nasopharyngitis"]}}